Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Is oral therapy with Repaglinide equivalent to insulin therapy with three daily injections
with respect to blood glucose control, weight and pulmonary function over 2 years in patients
with cystic fibrosis and secondary diabetes mellitus? That is the question examined in the
phase III trial.
Phase:
Phase 3
Details
Lead Sponsor:
Mukoviszidose Institut gGmbH
Collaborators:
Assistance Publique - Hôpitaux de Paris Mucoviscidose-ABCF2 Novo Nordisk A/S